Stay updated with breaking news from Ultraviolet Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
16.05.2022 - Quarterly Net Revenue Increased 79% Year-Over-Year to $24.2 Million, the Highest Revenue in Company HistoryStrategic Priorities Focused on Driving Revenue Growth, Increasing Financial Efficiencies and Performance and Preparing Pipeline for Long-term ...
14.02.2022 - Quarterly Net Revenue Increased 53% Year-over-year to $23.1 MillionPREVEnt Pivotal Study for AR101 in Vascular Ehlers-Danlos Syndrome On-track to Begin in Mid-2022Initiation of Randomized, Sham-controlled Study of Healight in Patients with ...
ENGLEWOOD, CO / ACCESSWIRE / November 23, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, announced